PT2948461T - Compostos e métodos para o tratamento de infeções bacterianas - Google Patents
Compostos e métodos para o tratamento de infeções bacterianasInfo
- Publication number
- PT2948461T PT2948461T PT147026421T PT14702642T PT2948461T PT 2948461 T PT2948461 T PT 2948461T PT 147026421 T PT147026421 T PT 147026421T PT 14702642 T PT14702642 T PT 14702642T PT 2948461 T PT2948461 T PT 2948461T
- Authority
- PT
- Portugal
- Prior art keywords
- compounds
- methods
- bacterial infections
- treating bacterial
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361755537P | 2013-01-23 | 2013-01-23 | |
| US201361859910P | 2013-07-30 | 2013-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2948461T true PT2948461T (pt) | 2020-03-31 |
Family
ID=50033593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT147026421T PT2948461T (pt) | 2013-01-23 | 2014-01-22 | Compostos e métodos para o tratamento de infeções bacterianas |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US8889671B2 (pt) |
| EP (1) | EP2948461B1 (pt) |
| JP (1) | JP6285960B2 (pt) |
| KR (1) | KR102149567B1 (pt) |
| CN (1) | CN105229012B (pt) |
| AR (1) | AR094565A1 (pt) |
| AU (1) | AU2014208965B2 (pt) |
| BR (1) | BR112015017519B1 (pt) |
| CA (1) | CA2897887C (pt) |
| CY (1) | CY1122805T1 (pt) |
| DK (1) | DK2948461T3 (pt) |
| EA (1) | EA026901B1 (pt) |
| ES (1) | ES2780824T3 (pt) |
| HK (1) | HK1218293A1 (pt) |
| HR (1) | HRP20200401T1 (pt) |
| HU (1) | HUE048990T2 (pt) |
| IL (1) | IL239860A0 (pt) |
| LT (1) | LT2948461T (pt) |
| ME (1) | ME03676B (pt) |
| MX (1) | MX360650B (pt) |
| MY (1) | MY192765A (pt) |
| NZ (1) | NZ710091A (pt) |
| PH (1) | PH12015501588B1 (pt) |
| PL (1) | PL2948461T3 (pt) |
| PT (1) | PT2948461T (pt) |
| RS (1) | RS60078B1 (pt) |
| SG (1) | SG11201505462YA (pt) |
| SI (1) | SI2948461T1 (pt) |
| TW (1) | TWI603973B (pt) |
| UY (1) | UY35274A (pt) |
| WO (1) | WO2014114929A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9040528B2 (en) * | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| US8889671B2 (en) * | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
| SG10201906842WA (en) * | 2014-05-29 | 2019-08-27 | Entasis Therapeutics Ltd | Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections |
| US10660933B2 (en) * | 2015-10-29 | 2020-05-26 | University Of Maryland, College Park | Compositions and methods for inhibition of bacterial infections in human endocervix |
| CN106632298B (zh) * | 2015-11-03 | 2021-06-01 | 上海科胜药物研发有限公司 | 一种泰地唑胺的制备方法及其中间体 |
| BR112019024950A2 (pt) | 2017-06-01 | 2020-06-23 | Bristol-Myers Squibb Company | Compostos contendo nitrogênio substituído |
| WO2018233670A1 (zh) * | 2017-06-22 | 2018-12-27 | 中国科学院上海药物研究所 | 苯并异噁唑螺嘧啶三酮类化合物及制备方法和用途 |
| CN109111465B (zh) * | 2017-06-22 | 2021-01-12 | 中国科学院上海药物研究所 | 噻唑烷酮螺嘧啶三酮类化合物及制备方法和用途 |
| CN109111466B (zh) * | 2017-06-22 | 2022-08-02 | 中国科学院上海药物研究所 | 苯并异噁唑螺嘧啶三酮类化合物及制备方法和用途 |
| CN108060207B (zh) * | 2017-12-29 | 2021-10-15 | 河南科技大学 | 一种基于微量天然化合物的最小杀菌浓度测定方法 |
| US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
| CN111559985A (zh) * | 2020-05-13 | 2020-08-21 | 河南科技大学第一附属医院 | 具有杀菌作用的噁唑酮类化合物及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0759570B2 (ja) | 1986-05-06 | 1995-06-28 | 三井東圧化学株式会社 | ２−オキサゾリジノン類の製造方法 |
| US7208490B2 (en) | 2002-10-07 | 2007-04-24 | Pharmacia & Upjohn Company Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| EP1664052B1 (en) | 2003-08-15 | 2009-02-18 | AstraZeneca AB | Fused heterocycles as inhibitors of glutamate racemase (muri) |
| US7361689B2 (en) | 2003-12-31 | 2008-04-22 | Schering-Plough Animal Health Corporation | Antibacterial 1-(4-mono- and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoroproponals and preparation thereof |
| JP2008543739A (ja) | 2005-05-09 | 2008-12-04 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | 抗菌剤 |
| DOP2006000268A (es) | 2005-12-22 | 2007-07-31 | Pfizer Prod Inc | Agentes antibacterianos |
| CL2007003332A1 (es) * | 2006-11-24 | 2008-06-20 | Actelion Pharmaceuticals Ltd | Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas. |
| JP2010531868A (ja) | 2007-07-02 | 2010-09-30 | アストラゼネカ アクチボラグ | ３−スピロピリミジントリオン−キノリン誘導体と抗菌剤としてのその使用 |
| US9040528B2 (en) | 2008-10-14 | 2015-05-26 | Astrazeneca Ab | Chemical compounds 542 |
| MX2011003598A (es) | 2008-10-14 | 2011-04-27 | Astrazeneca Ab | Compuestos heteroaromaticos espirociclicos, fusionados, para el tratamiento de infecciones bacterianas. |
| US8952149B2 (en) | 2012-09-26 | 2015-02-10 | Zoetis Llc | Tricyclic tetrahydroquinoline antibacterial agents |
| US8889671B2 (en) * | 2013-01-23 | 2014-11-18 | Astrazeneca Ab | Compounds and methods for treating bacterial infections |
-
2014
- 2014-01-21 US US14/159,773 patent/US8889671B2/en active Active
- 2014-01-22 CN CN201480017715.6A patent/CN105229012B/zh active Active
- 2014-01-22 EP EP14702642.1A patent/EP2948461B1/en active Active
- 2014-01-22 MY MYPI2015001807A patent/MY192765A/en unknown
- 2014-01-22 HU HUE14702642A patent/HUE048990T2/hu unknown
- 2014-01-22 LT LTEP14702642.1T patent/LT2948461T/lt unknown
- 2014-01-22 NZ NZ710091A patent/NZ710091A/en unknown
- 2014-01-22 SG SG11201505462YA patent/SG11201505462YA/en unknown
- 2014-01-22 EA EA201591362A patent/EA026901B1/ru unknown
- 2014-01-22 SI SI201431524T patent/SI2948461T1/sl unknown
- 2014-01-22 CA CA2897887A patent/CA2897887C/en active Active
- 2014-01-22 PT PT147026421T patent/PT2948461T/pt unknown
- 2014-01-22 BR BR112015017519-8A patent/BR112015017519B1/pt active IP Right Grant
- 2014-01-22 ES ES14702642T patent/ES2780824T3/es active Active
- 2014-01-22 PL PL14702642T patent/PL2948461T3/pl unknown
- 2014-01-22 MX MX2015009479A patent/MX360650B/es active IP Right Grant
- 2014-01-22 WO PCT/GB2014/050164 patent/WO2014114929A1/en active Application Filing
- 2014-01-22 AU AU2014208965A patent/AU2014208965B2/en active Active
- 2014-01-22 JP JP2015554245A patent/JP6285960B2/ja active Active
- 2014-01-22 DK DK14702642.1T patent/DK2948461T3/da active
- 2014-01-22 ME MEP-2020-55A patent/ME03676B/me unknown
- 2014-01-22 RS RS20200292A patent/RS60078B1/sr unknown
- 2014-01-22 KR KR1020157022580A patent/KR102149567B1/ko active IP Right Grant
- 2014-01-23 TW TW103102537A patent/TWI603973B/zh active
- 2014-01-23 UY UY0001035274A patent/UY35274A/es not_active Application Discontinuation
- 2014-01-23 AR ARP140100208A patent/AR094565A1/es active IP Right Grant
- 2014-10-16 US US14/515,684 patent/US9187495B2/en active Active
-
2015
- 2015-07-09 IL IL239860A patent/IL239860A0/en active IP Right Grant
- 2015-07-20 PH PH12015501588A patent/PH12015501588B1/en unknown
- 2015-10-13 US US14/881,595 patent/US9540394B2/en active Active
-
2016
- 2016-06-01 HK HK16106237.2A patent/HK1218293A1/zh unknown
- 2016-11-16 US US15/353,325 patent/US9839641B2/en active Active
-
2020
- 2020-03-11 HR HRP20200401TT patent/HRP20200401T1/hr unknown
- 2020-03-12 CY CY20201100217T patent/CY1122805T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1225649A1 (zh) | 用於治療細菌性感染的化合物和方法 | |
| EP2991638A4 (en) | METHODS OF TREATING BACTERIAL INFECTIONS | |
| HK1216389A1 (zh) | 治療局部微生物感染的方法 | |
| IL246087A0 (en) | Materials and methods for controlling inflammation | |
| HK1218293A1 (zh) | 治療細菌感染的化合物和方法 | |
| EP2991968A4 (en) | Compounds and methods of treating infections | |
| EP2953624A4 (en) | METHOD FOR THE TREATMENT OF MICROBIAL INFECTIONS, INCLUDING MASTITIS | |
| IL242770B (en) | A therapeutic combination that includes oxazolidinone-quinolones for use in the treatment of bacterial infections | |
| EP2994140A4 (en) | Methods for treating hcv infection | |
| HK1215164A1 (zh) | 處理方法 | |
| GB201212588D0 (en) | Colicins for treating bacterial infections | |
| HK1213268A1 (zh) | 用於治療細菌感染的甘露糖衍生物 | |
| EP3065550A4 (en) | Methods and compositions for treating sepsis | |
| ZA201503474B (en) | Compositions and methods for treating bacterial infections | |
| EP3060216A4 (en) | Methods for treating hcv | |
| EP2969003A4 (en) | METHOD AND COMPOSITIONS FOR BACTERIAL INFECTIONS | |
| EP2968497A4 (en) | COMPOSITIONS AND METHODS FOR TREATING FUNGAL AND BACTERIAL PATHOGENIC AGENTS | |
| EP2947462A4 (en) | SAMPLE PROCESSING SYSTEM | |
| IL249616A0 (en) | Methods for treating inflammation | |
| IL246185A0 (en) | Methods and compositions for treating dysregulation in systems | |
| EP3038615A4 (en) | Methods for treating bacterial infections using oritavancin and polymyxins | |
| GB201311984D0 (en) | Methods and compounds for preventing or treating osteoarthritis | |
| AU2013901517A0 (en) | Methods of Treating Bacterial Infections | |
| AU2013901516A0 (en) | Compounds and Methods of Treating Infections | |
| TH1501004125A (th) | สารประกอบและวิธีการสำหรับการรักษาการติดเชื้อแบคทีเรีย |